Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K12 | Q12852 | 3/20 | 0.43 |
| ▸ | DRD4 | P21917 | 3/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | HTR7 | P34969 | 2/20 | 0.33 |
| ▸ | DRD3 | P35462 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | EIF2AK4 | Q9P2K8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20456800 | 1.00 | MAP3K12 (0.43) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL20491963 | 0.94 | MAP3K12 (0.38) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL20469096 | 0.91 | MAP3K12 (0.39) | MAP3K12EIF2AK4 | |
| SCHEMBL20468998 | 0.91 | MAP3K12 (0.37) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL31447564 | 0.91 | MAP3K12 (0.37) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL20456717 | 0.91 | MAP3K12 (0.37) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL20456718 | 0.91 | MAP3K12 (0.37) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL21012851 | 0.85 | ALDH1A1 (0.33) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL24018502 | 0.83 | MAP3K12 (0.43) | MAP3K12DRD4HTR1AHTR2ASLC6A4 | |
| SCHEMBL20469202 | 0.83 | MAP3K12 (0.46) | MAP3K12DRD4HTR1AHTR2ASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3909949-A1 | ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS | Gilead Sciences, Inc. (US) | 2021-11-17 | — | — | EP | disclosed |